Hamid, Kardo .
HRN: 21-35-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/22/2022
08/29/2022
IV
200
Q8
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes